Guide of Hypertensive Crisis Pharmacotherapy

Title:Guide of Hypertensive Crisis Pharmacotherapy

Volume: 17 Issue: 1

Author(s): Priyanka Wani-Parekh*, Carlos Blanco-Garcia, Melissa Mendez and Debabrata Mukherjee

Affiliation:

• Department of Internal Medicine, Texas Tech University Health Science Center at El Paso, Paul L. Foster School of Medicine, 4800 Alberta Ave, El Paso, Texas, 79905,United States

Keywords: Hypertensive emergency, cardiovascular disease, antihypertensive medications, pregnancy, eclampsia.

Abstract: Background: Cardiovascular diseases (CVD) are the number one cause of death globally compared to any other cause. CVD accounts for approximately 17.3 million deaths per year and are rising. Hypertension is the leading risk factor for cardiovascular diseases. Approximately, 80 million people suffer from hypertension in the U.S. While, majority of these individuals are on antihypertensive medications only 54% of individuals with hypertension are optimally controlled. Heart failure and stroke are some of the devastating complications of uncontrolled hypertension. Hypertensive crisis can be classified as either an urgency or emergency; difference between the two is the presence of end organ damage, which is noted in hypertensive emergency. Hypertensive crisis is usually treated by parenteral antihypertensive medications. The main drug classes of drugs for treatment are nitrates, calcium channel blockers, dopamine-1 agonists, adrenergic-blocking agents etc.

Cite this article as:

Wani-Parekh Priyanka*, Blanco-Garcia Carlos , Mendez Melissa and Mukherjee Debabrata, Guide of Hypertensive Crisis Pharmacotherapy, Cardiovascular & Hematological Disorders-Drug Targets 2017; 17 (1) . https://dx.doi.org/10.2174/1871529X16666161220142020